David Scadden - 01 Jun 2021 Form 4 Insider Report for Magenta Therapeutics, Inc. (MGTA)

Role
Director
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for David Scadden
Issuer symbol
MGTA
Transactions as of
01 Jun 2021
Transactions value $
$0
Form type
4
Filing time
03 Jun 2021, 18:30:52 UTC
Previous filing
02 Jun 2021
Next filing
07 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGTA Stock Option (Right to Buy) Award $0 +18.2K $0.00 18.2K 01 Jun 2021 Common Stock 18.2K $12.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in full upon the earlier to occur of (a) June 1, 2022 or (b) the next annual meeting of the Issuer's stockholders.